NCT07146373 Effect of Inspiratory Muscle Training in Cognition
| NCT ID | NCT07146373 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of West Attica |
| Condition | Mild Cognitive Impairment (MCI) |
| Study Type | INTERVENTIONAL |
| Enrollment | 76 participants |
| Start Date | 2025-03-01 |
| Primary Completion | 2027-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 76 participants in total. It began in 2025-03-01 with a primary completion date of 2027-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to examine the effect of a respiratory muscle strengthening program on the cognitive and physical functioning of patients with neurocognitive disorders (Mild Cognitive Impairment) or those predisposed to them. The main questions that aims to answer are: 1. Is Inpsiratory Muscle Training (IMT) feasible in people with mild cognitive impairement? 2. Could Inspiratory Muscle Training (IMT) improve congitive function in people with mild cognitive impairement? 3. Could Inspiratory Musclre training improve physical function in this population? Participants will be: 1. \< 60 age or \> 90 age 2. MMSE (Mini Mental State Examination) score ≤ 28 and ≥ 18 and follow a high intensity IMT program along with a physical - cognitive program. or just the physical - cognitive program.
Eligibility Criteria
Inclusion Criteria: * MMSE (Mini Mental State Examination) score ≤ 28 και ≥ 18 * stable treatment related to medication Exclusion Criteria: * MMSE score \< 18 και \> 28 * psychological disorder * any contraindication to physical training
Contact & Investigator
IRINI PATSAKI, PhD
PRINCIPAL INVESTIGATOR
University of West Attica
Frequently Asked Questions
Who can join the NCT07146373 clinical trial?
This trial is open to participants of all sexes, aged 60 Years or older, up to 90 Years, studying Mild Cognitive Impairment (MCI). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07146373 currently recruiting?
Yes, NCT07146373 is actively recruiting participants. Contact the research team at ipatsaki@uniwa.gr for enrollment information.
Where is the NCT07146373 trial being conducted?
This trial is being conducted at Aigáleo, Greece.
Who is sponsoring the NCT07146373 clinical trial?
NCT07146373 is sponsored by University of West Attica. The principal investigator is IRINI PATSAKI, PhD at University of West Attica. The trial plans to enroll 76 participants.